Empowering appropriate antimicrobial use with rapid diagnostics.

C. difficile

C. difficile

Healthcare Associated Infections (HAIs) are a global concern causing significant mortality and morbidity as well as spiralling healthcare costs worldwide. Clostridium difficile is the most common cause of Healthcare Associated Diarrhea in industrialized countries.1 In North America, C. difficile is present in 13 of every 1,000 hospital inpatients2 and the estimated annual economic burden is approximately $3.2 billion.3